Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.5B | 15.0B | 14.3B | 14.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 7.6B | 6.6B | 7.0B | 6.7B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 5.5B | 4.9B | 4.2B | 4.1B |
| Tax provision | 1.2B | 1.2B | 995M | 957M |
| Net income | 4.4B | 3.7B | 3.2B | 3.1B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 4.4B | 3.7B | 3.2B | 3.1B |
| Minority interests | -56M | -10M | -38M | -41M |
| Preferred stock dividends | — | — | — | — |